Pharm Flashcards

1
Q

chemotherapeutic agents for breast cancer

A

Cyclophosphamide
Methotrexate
5-FU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

tamoxifen

A

selective estrogen receptor modulators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

AML Tx

A

7+3 (7 days of cytarabine (cytosine arabinoside), and 3 days daunorubicin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

best drug for nausea and vomiting**

A

dexamethasone (Decadron)

ondansetron (Zofran) also works well - 5-HT3 recep antag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

most commonly used chemotherapeutic agent for colon ca**

A

Antimetabolites (5-flourouracil)**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

adjuvant Tx for gastric ca**

A

Gleevec – 54% partial response
Extremely helpful in Locally invasive tumor
5 year survival 48%, recurrence 1st 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

epidermal growth factor receptor (EGFR)*

A

tumor marker currently studied as targeted therapy
mutation can cause lung ca in non-smokers
predominant in adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CML Tx

A

TKI: disease control, eg Gleevec (imatinib, Spyrcel, Taiga, Bosulif) - only affects ca cells, NOT cure
potential cure w/ allo hematopoietic transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Philadelphia neg ALL/LBL Tx adult

A

Hyper CVAD (cytoxan vincristine, daunorubicin, dexamethasone, alternating with methotrexate, cytarabine), nasty tx
Tx CNS w/methotrexate and cytarabine
G-CSF daily injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Philadelphia pos* ALL/LBL adult tx*

A

add TKI*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

CLL Tx

A

depends on indolent or active progression
cannot be cured
radiation therapy if localized
no single agreed upon Tx
70-95% CR (complete remission) rate with Fludarabine, cyclophosphamide, rituximab/Rituxan
and ibrutinib/Imbruvica

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tx of Hairy cell leukemia

A

no cure, observe initially
Chemo with cladribine (preferred) or pentostatin
interferon alfa if severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NHL ChemotherapyIndolent lymphomas*

A

CHOP or R-CHOP*** (rituximab/Rituxan, Cyclophosphamide, doxorubicin, vincristine, prednisone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NHL ChemotherapyAggressive Lymphomas

A

R-CHOP (FIRST LINE) rituximab, cyclophosphamide, doxorubicin, vincristine & prednisone
First line treatment for Activated B cell DLBCL: R-CHOP plus lenalidomide or ibrutinib or bortezomib
GAZYVA/(Obinutuzumab): showing better results than Rituxan
Tx targets CD20 B lymph antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hodgkin Lymphoma Tx

A

-Radiation therapy (stage I & II and some stage IIIa)ABVD (doxorubicin, bleomycin, vinblastine, decarbazine)
-Chemo for stage III b and IV
ABVD* (BIG DRUG THAT IS USED)
FAVORABLE PROGNOSIS; more relapse in stage 3,4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tx of multiple myeloma

A

if “smoldering”, observe
normally, immediate tx required or die in 6mon**
eval for transplantation
3 drug regime: Bortezomib/Velcade, plus Lenalidomide/Revlimid plus dexamethasone/Decadron (VRd)